278 related articles for article (PubMed ID: 25866209)
21. The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer.
Namgoong GM; Khanal P; Cho HG; Lim SC; Oh YK; Kang BS; Shim JH; Yoo JC; Choi HS
J Biol Chem; 2010 Jul; 285(31):23829-41. PubMed ID: 20479004
[TBL] [Abstract][Full Text] [Related]
22. Interaction and structural modification of topoisomerase IIalpha by peptidyl prolyl isomerase, pin1: an in silico study.
Mathur R; Suman S; Beaume N; Ali M; Bhatt AN; Chopra M; Saluja D; Mishra AK; Chandna S; Kapoor PN; Dwarakanath BS
Protein Pept Lett; 2010 Feb; 17(2):151-63. PubMed ID: 20214639
[TBL] [Abstract][Full Text] [Related]
23. Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions.
Messenger MM; Saulnier RB; Gilchrist AD; Diamond P; Gorbsky GJ; Litchfield DW
J Biol Chem; 2002 Jun; 277(25):23054-64. PubMed ID: 11940573
[TBL] [Abstract][Full Text] [Related]
24. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer.
Rustighi A; Tiberi L; Soldano A; Napoli M; Nuciforo P; Rosato A; Kaplan F; Capobianco A; Pece S; Di Fiore PP; Del Sal G
Nat Cell Biol; 2009 Feb; 11(2):133-42. PubMed ID: 19151708
[TBL] [Abstract][Full Text] [Related]
25. Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1.
Guillen-Quispe YN; Kim SJ; Saeidi S; Zhou T; Zheng J; Kim SH; Fang X; Chelakkot C; Rios-Castillo ME; Shin YK; Surh YJ
Free Radic Biol Med; 2023 Oct; 207():296-307. PubMed ID: 37473874
[TBL] [Abstract][Full Text] [Related]
26. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease.
Takahashi K; Uchida C; Shin RW; Shimazaki K; Uchida T
Cell Mol Life Sci; 2008 Feb; 65(3):359-75. PubMed ID: 17965833
[TBL] [Abstract][Full Text] [Related]
27. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
28. Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT.
Stanya KJ; Liu Y; Means AR; Kao HY
J Cell Biol; 2008 Oct; 183(1):49-61. PubMed ID: 18838553
[TBL] [Abstract][Full Text] [Related]
29. On the benefit of bivalency in peptide ligand/pin1 interactions.
Daum S; Lücke C; Wildemann D; Schiene-Fischer C
J Mol Biol; 2007 Nov; 374(1):147-61. PubMed ID: 17931657
[TBL] [Abstract][Full Text] [Related]
30. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
Ryo A; Liou YC; Lu KP; Wulf G
J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
[TBL] [Abstract][Full Text] [Related]
31. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage.
Wulf GM; Liou YC; Ryo A; Lee SW; Lu KP
J Biol Chem; 2002 Dec; 277(50):47976-9. PubMed ID: 12388558
[TBL] [Abstract][Full Text] [Related]
32. Proline isomerase Pin1 represses terminal differentiation and myocyte enhancer factor 2C function in skeletal muscle cells.
Magli A; Angelelli C; Ganassi M; Baruffaldi F; Matafora V; Battini R; Bachi A; Messina G; Rustighi A; Del Sal G; Ferrari S; Molinari S
J Biol Chem; 2010 Nov; 285(45):34518-27. PubMed ID: 20801874
[TBL] [Abstract][Full Text] [Related]
33. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.
Zhou XZ; Kops O; Werner A; Lu PJ; Shen M; Stoller G; Küllertz G; Stark M; Fischer G; Lu KP
Mol Cell; 2000 Oct; 6(4):873-83. PubMed ID: 11090625
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
35. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation.
Liao Y; Wei Y; Zhou X; Yang JY; Dai C; Chen YJ; Agarwal NK; Sarbassov D; Shi D; Yu D; Hung MC
Oncogene; 2009 Jul; 28(26):2436-45. PubMed ID: 19448664
[TBL] [Abstract][Full Text] [Related]
36. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
[TBL] [Abstract][Full Text] [Related]
37. Stereospecific gating of functional motions in Pin1.
Namanja AT; Wang XJ; Xu B; Mercedes-Camacho AY; Wilson KA; Etzkorn FA; Peng JW
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12289-94. PubMed ID: 21746900
[TBL] [Abstract][Full Text] [Related]
38. Cytosolic Aryl sulfotransferase 4A1 interacts with the peptidyl prolyl cis-trans isomerase Pin1.
Mitchell DJ; Minchin RF
Mol Pharmacol; 2009 Aug; 76(2):388-95. PubMed ID: 19439498
[TBL] [Abstract][Full Text] [Related]
39. Pin1 modulates the dephosphorylation of the RNA polymerase II C-terminal domain by yeast Fcp1.
Kops O; Zhou XZ; Lu KP
FEBS Lett; 2002 Feb; 513(2-3):305-11. PubMed ID: 11904169
[TBL] [Abstract][Full Text] [Related]
40. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.
Ryo A; Nakamura M; Wulf G; Liou YC; Lu KP
Nat Cell Biol; 2001 Sep; 3(9):793-801. PubMed ID: 11533658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
